| (+)-Arhalofenate |
|
|
|
|
|
99.85% |
| (+)-Licarin |
|
|
|
|
|
|
| (10E,12E)-9-Oxo-10,12-octadecadienoic acid |
|
|
|
|
|
96.00% |
| (10E,12Z)-Octadeca-10,12-dienoic acid |
|
|
|
|
|
99.1% |
| (3R,5R)-3,5-Dihydroxy-1,7-bis(3,4-dihydroxyphenyl)heptane 3-O-β-D-glucopyranoside |
|
|
|
|
|
|
| (E)-CLX-0921 |
|
|
|
|
|
98.17% |
| (E)-Osmundacetone |
|
|
|
|
|
99.81% |
| (E)-Osmundacetone (Standard) |
|
|
|
|
|
|
| (E/Z)-ABP/PPAR modulator 1 |
|
|
|
|
|
97.22% |
| (E/Z)-Elafibranor |
|
|
|
|
|
98.36% |
| (E/Z)-Oleamide |
|
|
|
|
|
99.97% |
| (R)-Pioglitazone |
|
|
|
|
|
|
| (S)-Coriolic acid |
|
|
|
|
|
99% |
| (±)-CBCQ |
|
|
|
|
|
|
| (±)4-HDHA |
|
|
|
|
|
97.97% |
| (±)8(9)-EET |
|
|
|
|
|
|
| 3-Thiatetradecanoic acid |
|
|
|
|
|
|
| 1,2-DLPC |
|
|
|
|
|
98.0% |
| 1-Methyladenosine |
|
|
|
|
|
99.92% |
| 1-Methyladenosine-d3 |
|
|
|
|
|
96.12% |
| 1-Methyladenosine-d3 hydriodide |
|
|
|
|
|
99.87% |
| 1-Methyladenosine-d3 hydrochloride |
|
|
|
|
|
98.05% |
| 1-O-Hexadecylglycerol |
|
|
|
|
|
99.96% |
| 10-Nitrolinoleic acid |
|
|
|
|
|
95.0% |
| 10-Hydroxystearic acid |
|
|
|
|
|
99.94% |
| 12-Nitrolinoleate |
|
|
|
|
|
|
| 13-Oxo-ODE |
|
|
|
|
|
98.46% |
| 13-Oxo-9E,11E-octadecadienoic acid |
|
|
|
|
|
|
| 15-Deoxy-Δ-12,14-prostaglandin J2 |
|
|
|
|
|
97.0% |
| 15-Deoxy-Δ-12,14-prostaglandin J2-d4 |
|
|
|
|
|
98.10% |
| 15-deoxy-Δ12,14-Prostaglandin D2 |
|
|
|
|
|
98.0% |
| 15-deoxy-Δ12,14-Prostaglandin D2-d4 |
|
|
|
|
|
|
| 15-Deoxy-Δ12,14-Prostaglandin J2-2-glyceryl ester |
|
|
|
|
|
|
| 15-keto-Prostaglandin E2 |
|
|
|
|
|
99.0% |
| 15-LOX-IN-2 |
|
|
|
|
|
|
| 17(S)-HDHA |
|
|
|
|
|
|
| 17-Oxo-4(Z),7(Z),10(Z),13(Z),15(E),19(Z)-docosahexaenoic acid |
|
|
|
|
|
|
| 17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid |
|
|
|
|
|
|
| Fisetin quarterhydrate |
|
|
|
|
|
95.89% |
| 2-(Tetradecylthio)acetic acid |
|
|
|
|
|
99.81% |
| 2-Ethylhexyl diphenyl phosphate |
|
|
|
|
|
94.27% |
| 20-Carboxyarachidonic acid |
|
|
|
|
|
99.4% |
| 20-HEPE |
|
|
|
|
|
|
| 23-epi-26-Deoxyactein |
|
|
|
|
|
98.65% |
| Alisol A 24-acetate |
|
|
|
|
|
98.0% |
| 25-Hydroxytachysterol3 |
|
|
|
|
|
98.07% |
| Methyl oleanonate |
|
|
|
|
|
99.93% |
| 4,5-DiHDPA lactone |
|
|
|
|
|
|
| 4-O-Methyl honokiol |
|
|
|
|
|
98.76% |
| 4-Oxo Docosahexaenoic Acid |
|
|
|
|
|
|
| Isobutylparaben |
|
|
|
|
|
98.87% |
| Isobutylparaben-d4 |
|
|
|
|
|
98.5% |
| 4010B-30 |
|
|
|
|
|
|
| 4β-Hydroxywithanolide E |
|
|
|
|
|
98% |
| 5-Aminosalicylic acid-13C6 hydrochloride |
|
|
|
|
|
99.53% |
| 5-cis Carbaprostacyclin |
|
|
|
|
|
|
| Cloxiquine |
|
|
|
|
|
99.94% |
| 6-Thioinosine |
|
|
|
|
|
99.31% |
| 7,8-Didehydrocimigenol |
|
|
|
|
|
|
| 8(9)-EET |
|
|
|
|
|
|
| 8(S)-HETE |
|
|
|
|
|
99.9% |
| 9''-Methyl salvianolate B |
|
|
|
|
|
99.54% |
| 9(10)-Nitrooleate |
|
|
|
|
|
|
| 9(S)-HOTrE |
|
|
|
|
|
99.9% |
| CAY10410 |
|
|
|
|
|
|
| 9-HEPE |
|
|
|
|
|
99.9% |
| ABP/PPAR modulator 1 |
|
|
|
|
|
|
| Acetic acid lead |
|
|
|
|
|
|
| AD-5075 |
|
|
|
|
|
|
| AdipoR agonist 1 |
|
|
|
|
|
|
| AI 3-25755 |
|
|
|
|
|
|
| Alisol A |
|
|
|
|
|
99.59% |
| Alisol A (Standard) |
|
|
|
|
|
|
| Aluminium clofibrate |
|
|
|
|
|
|
| AM3102 |
|
|
|
|
|
98.0% |
| AM9053 |
|
|
|
|
|
98.36% |
| Amezalpat |
|
|
|
|
|
99.85% |
| AMG131 |
|
|
|
|
|
98.99% |
| AMG131 benzenesulfonate |
|
|
|
|
|
|
| Amorfrutin B |
|
|
|
|
|
97% |
| Anandamide-d8 |
|
|
|
|
|
99.9% |
| Anti-NASH agent 1 |
|
|
|
|
|
98.49% |
| Anti-NASH agent 2 |
|
|
|
|
|
|
| Anti-obesity agent 1 |
|
|
|
|
|
|
| Anti-osteoporosis agent-10 |
|
|
|
|
|
|
| Apo-12'-lycopenal |
|
|
|
|
|
|
| ATRA-biotin |
|
|
|
|
|
98.43% |
| AVE-8134 |
|
|
|
|
|
|
| AZD4619 |
|
|
|
|
|
|
| Azemiglitazone |
|
|
|
|
|
97.35% |
| Azemiglitazone potassium |
|
|
|
|
|
98.94% |
| BAY-0069 |
|
|
|
|
|
98.07% |
| BAY-4931 |
|
|
|
|
|
98.72% |
| BAY-5094 |
|
|
|
|
|
98.04% |
| BAY-5516 |
|
|
|
|
|
98.17% |
| BAY-9683 |
|
|
|
|
|
|
| BGT-002 |
|
|
|
|
|
99.35% |
| BM 170249 |
|
|
|
|
|
|
| BM152054 |
|
|
|
|
|
|
| BML-260 |
|
|
|
|
|
99.65% |
| BMS-195614 |
|
|
|
|
|
99.5% |
| BMS-687453 |
|
|
|
|
|
99.31% |
| BMS-687453 (Standard) |
|
|
|
|
|
|
| BMS711939 |
|
|
|
|
|
|
| Bocidelpar |
|
|
|
|
|
98.08% |
| BR101549 |
|
|
|
|
|
|
| BVT.13 |
|
|
|
|
|
98.44% |
| C333H |
|
|
|
|
|
|
| Calenduloside E |
|
|
|
|
|
99.07% |
| CAY10506 |
|
|
|
|
|
|
| CAY10514 |
|
|
|
|
|
|
| CC618 |
|
|
|
|
|
99.94% |
| CCT-010354 |
|
|
|
|
|
99.10% |
| CDDO-Im |
|
|
|
|
|
99.30% |
| Cevoglitazar |
|
|
|
|
|
97.00% |
| CF-Carvacrol |
|
|
|
|
|
|
| CF-Vanillin |
|
|
|
|
|
|
| Chiglitazar |
|
|
|
|
|
99.70% |
| Chiglitazar sodium |
|
|
|
|
|
98.33% |
| Cichoriin |
|
|
|
|
|
99.9% |
| Cinoxate |
|
|
|
|
|
|
| Cinoxate-d3 |
|
|
|
|
|
|
| Ciprofibrate impurity A |
|
|
|
|
|
|
| CLX-0921 |
|
|
|
|
|
|
| CP-775146 |
|
|
|
|
|
98.70% |
| CP-868388 free base |
|
|
|
|
|
99.08% |
| CRX000227 |
|
|
|
|
|
95.0% |
| CS4 |
|
|
|
|
|
|
| CUDA |
|
|
|
|
|
99.83% |
| CUDA disodium |
|
|
|
|
|
98.0% |
| CUDA-d11 |
|
|
|
|
|
|
| D-Arabinose |
|
|
|
|
|
98.0% |
| D-Arabinose-13C |
|
|
|
|
|
|
| D-Arabinose-13C-1 |
|
|
|
|
|
|
| D-arabinose-13C-2 |
|
|
|
|
|
|
| D-Arabinose-13C-3 |
|
|
|
|
|
|
| D-Arabinose-d2 |
|
|
|
|
|
|
| D-Arabinose-d5 |
|
|
|
|
|
|
| D-Arabinose-d6 |
|
|
|
|
|
|
| D-Arabinopyranose |
|
|
|
|
|
99.94% |
| D-Arabinopyranose-13C5 |
|
|
|
|
|
99.9% |
| DB-959 |
|
|
|
|
|
|
| Dehydroabietic acid |
|
|
|
|
|
98.52% |
| Dehydroepiandrosterone sulfate |
|
|
|
|
|
99.93% |
| Dehydroepiandrosterone sulfate (Standard) |
|
|
|
|
|
99.93% |
| Dehydroepiandrosterone sulfate sodium-d6 |
|
|
|
|
|
99.61% |
| Dehydroepiandrosterone sulfate-d6 sodium dihydrate |
|
|
|
|
|
98.00% |
| Demethoxyfumitremorgin C |
|
|
|
|
|
|
| Deutaleglitazar |
|
|
|
|
|
|
| DG172 dihydrochloride |
|
|
|
|
|
99.51% |
| DN-108 |
|
|
|
|
|
|
| DN203316 |
|
|
|
|
|
|
| Dovitinib-RIBOTAC |
|
|
|
|
|
99.31% |
| Dovitinib-RIBOTAC TFA |
|
|
|
|
|
98.35% |
| DRF-2519 free base |
|
|
|
|
|
|
| Drupanin |
|
|
|
|
|
99.35% |
| DS-6930 |
|
|
|
|
|
|
| DSO-5a |
|
|
|
|
|
|
| dual FXR/PPARδ agonist-2 |
|
|
|
|
|
|
| E-3030 free acid |
|
|
|
|
|
|
| E0924G |
|
|
|
|
|
99.17% |
| E17241 |
|
|
|
|
|
95.04% |
| EL244 |
|
|
|
|
|
99.55% |
| Elafibranor |
|
|
|
|
|
99.66% |
| Elafibranor sulfoxide |
|
|
|
|
|
95.0% |
| Elaidyl-sulfamide |
|
|
|
|
|
|
| EPI-001 |
|
|
|
|
|
99.34% |
| Eriocalyxin B |
|
|
|
|
|
99.93% |
| Ertiprotafib |
|
|
|
|
|
98.13% |
| ESP-31015 |
|
|
|
|
|
|
| Etrinabdione |
|
|
|
|
|
99.16% |
| F44-A13 |
|
|
|
|
|
96.73% |
| Farglitazar |
|
|
|
|
|
99.50% |
| Fenofibrate |
|
|
|
|
|
|
| FH535 |
|
|
|
|
|
99.95% |
| FK614 |
|
|
|
|
|
99.97% |
| Flindersine |
|
|
|
|
|
99.80% |
| Fmoc-Ala-OH-13C3 |
|
|
|
|
|
98.5% |
| Fmoc-leucine |
|
|
|
|
|
99.9% |
| Fmoc-leucine-13C |
|
|
|
|
|
99.90% |
| Fmoc-leucine-13C6,15N |
|
|
|
|
|
95.12% |
| Fmoc-leucine-d10 |
|
|
|
|
|
99.40% |
| Fmoc-leucine-d3 |
|
|
|
|
|
99.25% |
| Foenumoside B |
|
|
|
|
|
|
| Fonadelpar |
|
|
|
|
|
|
| FSVVPSPK |
|
|
|
|
|
|
| FTX-6746 |
|
|
|
|
|
99.07% |
| FX-909 |
|
|
|
|
|
99.79% |
| Garcinia cambogia extract |
|
|
|
|
|
|
| GED 0507-34-Levo |
|
|
|
|
|
|
| Gemfibrozil 1-O-β-glucuronide-d6 |
|
|
|
|
|
|
| Gemfibrozil-d6-1 |
|
|
|
|
|
|
| Ginsenoside F2 |
|
|
|
|
|
99.92% |
| GQ-16 |
|
|
|
|
|
98.12% |
| GSK 1997132B |
|
|
|
|
|
|
| GSK-7227 |
|
|
|
|
|
|
| GSK0660 |
|
|
|
|
|
99.49% |
| GSK1820795A |
|
|
|
|
|
99.80% |
| GSK376501A |
|
|
|
|
|
99.06% |
| GSK3787 |
|
|
|
|
|
99.94% |
| GW 2433 |
|
|
|
|
|
|
| GW 501516 |
|
|
|
|
|
99.27% |
| GW 590735 |
|
|
|
|
|
99.44% |
| GW 590735 sodium |
|
|
|
|
|
|
| GW 9578 |
|
|
|
|
|
99.6% |
| GW-9820 |
|
|
|
|
|
|
| GW0072 |
|
|
|
|
|
|
| GW0742 |
|
|
|
|
|
99.64% |
| GW1929 |
|
|
|
|
|
99.93% |
| GW1929 hydrochloride |
|
|
|
|
|
|
| GW409544 |
|
|
|
|
|
|
| GW6471 |
|
|
|
|
|
99.64% |
| GW7647 |
|
|
|
|
|
99.45% |
| GW7845 |
|
|
|
|
|
|
| GW9662 |
|
|
|
|
|
99.98% |
| GW9662-d5 |
|
|
|
|
|
|
| H-Trp-Glu-OH |
|
|
|
|
|
99.95% |
| Halofenate |
|
|
|
|
|
|
| HD202A |
|
|
|
|
|
|
| Hexapeptide-9 |
|
|
|
|
|
99.28% |
| HSD17B13/PPAR modulator-1 |
|
|
|
|
|
|
| HWL-088 |
|
|
|
|
|
98.61% |
| Hydrangeic acid |
|
|
|
|
|
|
| Icosabutate |
|
|
|
|
|
97.28% |
| Imiglitazar |
|
|
|
|
|
|
| Inclisiran sodium scrambled negative control |
|
|
|
|
|
|
| Indeglitazar |
|
|
|
|
|
98.52% |
| Inolitazone hydrochloride hydrate |
|
|
|
|
|
|
| IR-251 |
|
|
|
|
|
|
| ISX-1 |
|
|
|
|
|
98.05% |
| ISX-3 |
|
|
|
|
|
99.68% |
| K-111 |
|
|
|
|
|
|
| KD-3010 |
|
|
|
|
|
|
| Ketopioglitazone |
|
|
|
|
|
|
| Kihadanin B |
|
|
|
|
|
|
| KRP-101 |
|
|
|
|
|
|
| KRP-105 |
|
|
|
|
|
|
| KRP-297 |
|
|
|
|
|
|
| L-165041 |
|
|
|
|
|
99.12% |
| L-764406 |
|
|
|
|
|
|
| L-783483 |
|
|
|
|
|
|
| L-796449 |
|
|
|
|
|
|
| γ-Glutamylvaline |
|
|
|
|
|
99.94% |
| LCI765 |
|
|
|
|
|
|
| Leriglitazone |
|
|
|
|
|
99.23% |
| Leriglitazone hydrochloride |
|
|
|
|
|
99.64% |
| Leriglitazone-d4 |
|
|
|
|
|
|
| Levistolide A |
|
|
|
|
|
99.34% |
| Licarin B |
|
|
|
|
|
99.93% |
| Licarin B-d4 |
|
|
|
|
|
|
| LJ570 |
|
|
|
|
|
|
| Lobeglitazone sulfate |
|
|
|
|
|
99.63% |
| Lophenol |
|
|
|
|
|
|
| LS2265 |
|
|
|
|
|
|
| LT175 |
|
|
|
|
|
99.46% |
| LTD4 antagonist 3 |
|
|
|
|
|
|
| LY-510929 |
|
|
|
|
|
|
| LY518674 |
|
|
|
|
|
98.50% |
| Lyciumamide A |
|
|
|
|
|
|
| MA-0204 |
|
|
|
|
|
99.31% |
| Mavodelpar |
|
|
|
|
|
99.93% |
| Mavodelpar free acid |
|
|
|
|
|
|
| MBX-102 acid |
|
|
|
|
|
|
| MD001 |
|
|
|
|
|
|
| Methyl clofenapate |
|
|
|
|
|
99.04% |
| Methyl dehydroabietate |
|
|
|
|
|
99.89% |
| MHY 553 |
|
|
|
|
|
|
| MHY908 |
|
|
|
|
|
|
| Mifobate |
|
|
|
|
|
99.85% |
| MK-886 |
|
|
|
|
|
99.77% |
| MK-886 sodium salt |
|
|
|
|
|
|
| MMPP |
|
|
|
|
|
98.06% |
| Monoethyl phthalate |
|
|
|
|
|
98.58% |
| Monoethyl phthalate-d4 |
|
|
|
|
|
98.27% |
| MRL-24 |
|
|
|
|
|
99.58% |
| MRL20 |
|
|
|
|
|
|
| MTX-531 |
|
|
|
|
|
99.87% |
| Muraglitazar |
|
|
|
|
|
98.38% |
| N-Desmethyl rosiglitazone |
|
|
|
|
|
|
| N-Octadecyl-N'-propyl-sulfamide |
|
|
|
|
|
|
| Naveglitazar |
|
|
|
|
|
99.47% |
| NC-2100 |
|
|
|
|
|
|
| Neoambrosin |
|
|
|
|
|
|
| Neopterin |
|
|
|
|
|
99.95% |
| Netoglitazone |
|
|
|
|
|
99.92% |
| NO-Pravastatin |
|
|
|
|
|
|
| Nor-LY-510929 |
|
|
|
|
|
|
| NS-220 |
|
|
|
|
|
|
| nTZDpa |
|
|
|
|
|
98.53% |
| NVP-TNKS656 |
|
|
|
|
|
|
| NXT629 |
|
|
|
|
|
98.75% |
| Ochratoxin A-D4 |
|
|
|
|
|
|
| Octocrylene-13C3 |
|
|
|
|
|
|
| Oleoylethanolamide |
|
|
|
|
|
98.19% |
| Oleoylethanolamide-d2 |
|
|
|
|
|
|
| Oleoylethanolamide-d4 |
|
|
|
|
|
|
| OLHHA |
|
|
|
|
|
|
| Oroxin A |
|
|
|
|
|
99.76% |
| Oroxylin A-7-O-glucuronide |
|
|
|
|
|
99.83% |
| Oxeglitazar |
|
|
|
|
|
|
| PA-082 |
|
|
|
|
|
|
| Palacaparib |
|
|
|
|
|
98.30% |
| Palmitoyllactic acid |
|
|
|
|
|
99.89% |
| Peliglitazar |
|
|
|
|
|
|
| Pemafibrate |
|
|
|
|
|
99.85% |
| Pemafibrate-d4 |
|
|
|
|
|
99.80% |
| Pentadecanoic acid |
|
|
|
|
|
99.92% |
| Perfluoro(2-methyl-3-oxahexanoic) acid |
|
|
|
|
|
98.0% |
| Perfluorobutanesulfonic acid |
|
|
|
|
|
98.0% |
| Perfluorobutanesulfonic acid-13C3 sodium |
|
|
|
|
|
|
| Petasin |
|
|
|
|
|
|
| PIISVYWK |
|
|
|
|
|
|
| Pioglitazone-d4 hydrochloride |
|
|
|
|
|
|
| Pirinixic acid |
|
|
|
|
|
99.34% |
| Porphyra 334 |
|
|
|
|
|
99.58% |
| PPAR agonist 1 |
|
|
|
|
|
98.39% |
| PPAR agonist 4 |
|
|
|
|
|
|
| PPAR agonist 5 |
|
|
|
|
|
97.16% |
| PPAR agonist 6 |
|
|
|
|
|
|
| PPAR agonist 7 |
|
|
|
|
|
|
| PPAR agonist 8 |
|
|
|
|
|
|
| PPARA Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Ppara Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Ppara Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| PPARD Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Ppard Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Ppard Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| PPARG Human Pre-designed siRNA Set A |
|
|
|
|
|
|
| Pparg Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
| Pparg Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
| PPARα agonist 1 |
|
|
|
|
|
|
| PPARα agonist 2 |
|
|
|
|
|
|
| PPARα agonist 3 |
|
|
|
|
|
|
| PPARα agonist 4 |
|
|
|
|
|
|
| PPARα agonist 5 |
|
|
|
|
|
|
| PPARα agonist 6 |
|
|
|
|
|
99.79% |
| PPARα-MO-1 |
|
|
|
|
|
|
| PPARα/γ agonist 1 |
|
|
|
|
|
99.69% |
| PPARα/γ agonist 2 |
|
|
|
|
|
|
| PPARα/γ agonist 3 |
|
|
|
|
|
|
| PPARα/γ agonist 4 |
|
|
|
|
|
|
| PPARα/γ agonist 5 |
|
|
|
|
|
|
| PPARα/γ/δ agonist 1 |
|
|
|
|
|
|
| PPARα/δ agonist 1 |
|
|
|
|
|
99.59% |
| PPARα/δ agonist 2 |
|
|
|
|
|
|
| PPARα/δ agonist 3 |
|
|
|
|
|
|
| PPARα/δ agonist 4 |
|
|
|
|
|
|
| PPARα/δ antagonist-1 |
|
|
|
|
|
|
| PPARγ agonist 1 |
|
|
|
|
|
|
| PPARγ agonist 10 |
|
|
|
|
|
|
| PPARγ agonist 11 |
|
|
|
|
|
99.9% |
| PPARγ agonist 12 |
|
|
|
|
|
|
| PPARγ agonist 14 |
|
|
|
|
|
98.0% |
| PPARγ agonist 15 |
|
|
|
|
|
|
| PPARγ agonist 16 |
|
|
|
|
|
|
| PPARγ agonist 17 |
|
|
|
|
|
|
| PPARγ agonist 19 |
|
|
|
|
|
|
| PPARγ agonist 2 |
|
|
|
|
|
|
| PPARγ agonist 20 |
|
|
|
|
|
|
| PPARγ agonist 3 |
|
|
|
|
|
|
| PPARγ agonist 4 |
|
|
|
|
|
|
| PPARγ agonist 5 |
|
|
|
|
|
98.59% |
| PPARγ agonist 6 |
|
|
|
|
|
|
| PPARγ agonist 7 |
|
|
|
|
|
|
| PPARγ agonist 8 |
|
|
|
|
|
|
| PPARγ agonist 9 |
|
|
|
|
|
|
| PPARγ agonist-21 |
|
|
|
|
|
|
| PPARγ agonist-22 |
|
|
|
|
|
|
| PPARγ agonist-23 |
|
|
|
|
|
|
| PPARγ modulator-1 |
|
|
|
|
|
|
| PPARγ modulator-2 |
|
|
|
|
|
|
| PPARγ modulator-3 |
|
|
|
|
|
|
| PPARγ modulator-4 |
|
|
|
|
|
|
| PPARγ phosphorylation inhibitor 1 |
|
|
|
|
|
99.81% |
| PPARγ-IN-2 |
|
|
|
|
|
99.65% |
| PPARγ-IN-3 |
|
|
|
|
|
|
| PPARγ-IN-5 |
|
|
|
|
|
|
| PPARγ/GR modulator 1 |
|
|
|
|
|
|
| PPARγ/δ modulator 1 |
|
|
|
|
|
|
| PPARγ/δ modulator 2 |
|
|
|
|
|
|
| Pparδ agonist 1 |
|
|
|
|
|
|
| PPARδ agonist 10 |
|
|
|
|
|
|
| PPARδ agonist 12 |
|
|
|
|
|
|
| PPARδ agonist 13 |
|
|
|
|
|
|
| Pparδ agonist 2 |
|
|
|
|
|
|
| Pparδ agonist 5 |
|
|
|
|
|
|
| Pparδ agonist 7 |
|
|
|
|
|
|
| PPARδ agonist 8 |
|
|
|
|
|
|
| PPARδ agonist 9 |
|
|
|
|
|
|
| PPARδ/γ agonist 1 sodium |
|
|
|
|
|
98.86% |
| Procyanidin C2 |
|
|
|
|
|
|
| Prostaglandin A3 |
|
|
|
|
|
|
| Prostaglandin B3 |
|
|
|
|
|
|
| Psammaplin A |
|
|
|
|
|
96.0% |
| PT-S58 |
|
|
|
|
|
|
| PTGR2-IN-1 |
|
|
|
|
|
99.82% |
| Rac-Pemafibrate |
|
|
|
|
|
|
| Rac-Pemafibrate-13C,d3 |
|
|
|
|
|
|
| Ragaglitazar |
|
|
|
|
|
99.24% |
| RB394 |
|
|
|
|
|
|
| Reglitazar |
|
|
|
|
|
|
| Retinoic acid |
|
|
|
|
|
|
| Retinoic acid-d3 |
|
|
|
|
|
|
| Retinoic acid-d3-1 |
|
|
|
|
|
|
| RG-12525 |
|
|
|
|
|
98.31% |
| Rivoglitazone |
|
|
|
|
|
98.59% |
| Rivoglitazone hydrochloride |
|
|
|
|
|
|
| Romazarit |
|
|
|
|
|
|
| Ronifibrate |
|
|
|
|
|
|
| S-Petasin |
|
|
|
|
|
|
| S26948 |
|
|
|
|
|
|
| Saringosterol |
|
|
|
|
|
|
| SB-219994 |
|
|
|
|
|
|
| SC-236 |
|
|
|
|
|
99.59% |
| SDPC |
|
|
|
|
|
98.0% |
| sEH/PPARδ modulator 1 |
|
|
|
|
|
|
| Seladelpar |
|
|
|
|
|
99.53% |
| Seladelpar (lysine dihydrate) |
|
|
|
|
|
99.51% |
| Seladelpar (lysine) |
|
|
|
|
|
98.0% |
| Seladelpar sodium |
|
|
|
|
|
98.59% |
| Sipoglitazar |
|
|
|
|
|
|
| Sitofibrate |
|
|
|
|
|
|
| SKLB102 |
|
|
|
|
|
98.0% |
| Sodelglitazar |
|
|
|
|
|
|
| Sodium propionate-13C |
|
|
|
|
|
99.6% |
| SP-C01 |
|
|
|
|
|
|
| SP4e |
|
|
|
|
|
99.72% |
| SP4f |
|
|
|
|
|
99.77% |
| SR 11023 |
|
|
|
|
|
99.55% |
| SR 16832 |
|
|
|
|
|
99.58% |
| SR 1824 |
|
|
|
|
|
|
| SR-1903 |
|
|
|
|
|
|
| SR10221 |
|
|
|
|
|
98.96% |
| SR1664 |
|
|
|
|
|
98.12% |
| SR2595 |
|
|
|
|
|
|
| ST247 |
|
|
|
|
|
99.88% |
| T0070907 |
|
|
|
|
|
99.94% |
| T2384 |
|
|
|
|
|
|
| TBBPA-sulfate |
|
|
|
|
|
|
| Tesaglitazar |
|
|
|
|
|
99.08% |
| Tibesaikosaponin V |
|
|
|
|
|
|
| Timcodar |
|
|
|
|
|
99.66% |
| trans-Cinnamyl alcohol |
|
|
|
|
|
99.51% |
| Triphenyl phosphate-d15 |
|
|
|
|
|
99.55% |
| Triumbelletin |
|
|
|
|
|
98.0% |
| TZD18 |
|
|
|
|
|
|
| Urolithin D |
|
|
|
|
|
99.72% |
| Vitisin A |
|
|
|
|
|
96% |
| VSP-77 |
|
|
|
|
|
|
| Vutiglabridin |
|
|
|
|
|
99.30% |
| WAY-120744 |
|
|
|
|
|
|
| Wistin |
|
|
|
|
|
97.63% |
| WWL229 |
|
|
|
|
|
99.49% |
| XYQ3-B11 |
|
|
|
|
|
|
| YGL-12 |
|
|
|
|
|
|
| YGT-31 |
|
|
|
|
|
|
| YM440 |
|
|
|
|
|
|
| YS121 |
|
|
|
|
|
99.74% |
| Zaltoprofen sulfoxide |
|
|
|
|
|
|
| ZINC08438472 |
|
|
|
|
|
|
| ZINC17167211 |
|
|
|
|
|
|
| ZLY032 |
|
|
|
|
|
|
| ZLY06 |
|
|
|
|
|
98.75% |
| β-Amyrone |
|
|
|
|
|
99.87% |
| Sodium acetate trihydrate, 99.5% |
|
|
|
|
|
99.99% |
| Propanoic acid |
|
|
|
|
|
99.20% |
| Propanoic acid-13C3 |
|
|
|
|
|
|
| Propanoic acid-d3 |
|
|
|
|
|
99.83% |
| Propanoic acid-d5 |
|
|
|
|
|
99.94% |
| Sodium propionate |
|
|
|
|
|
99.0% |
| Sodium propionate-13C-1 |
|
|
|
|
|
|
| Sodium propionate-13C2 |
|
|
|
|
|
|
| Sodium propionate-13C3 |
|
|
|
|
|
99.2% |
| Sodium propionate-d3 |
|
|
|
|
|
99.88% |
| Sodium propionate-d5 |
|
|
|
|
|
99.91% |
| Acetic acid |
|
|
|
|
|
99.65% |
| Acetic Acid-13C,d3-1 |
|
|
|
|
|
|
| Acetic acid-d1 |
|
|
|
|
|
|
| Sodium acetate trihydrate, meets analytical specification of Ph. Eur. BP USP FCC E262, ≤0.00002% Al |
|
|
|
|
|
100.4% |
| Sodium acetate trihydrate, United States Pharmacopeia (USP) Reference Standard |
|
|
|
|
|
|
| Magnesium acetate tetrahydrate |
|
|
|
|
|
99.47% |
| Tartronic acid |
|
|
|
|
|
98.0% |
| Ginsenoside Rh1 (Standard) |
|
|
|
|
|
|
| Ginsenoside Rh1 |
|
|
|
|
|
98.72% |
| Agrimol B |
|
|
|
|
|
99.50% |
| Inolitazone |
|
|
|
|
|
|
| Edaglitazone |
|
|
|
|
|
99.57% |
| 1,1'-(Azodicarbonyl)-dipiperidine |
|
|
|
|
|
97.0% |
| Caulophyllogenin |
|
|
|
|
|
|
| Glabrone |
|
|
|
|
|
99.08% |
| Glabridin |
|
|
|
|
|
99.91% |
| Glabridin (Standard) |
|
|
|
|
|
99.86% |
| Perfluorotetradecanoic acid |
|
|
|
|
|
98.0% |
| Perfluorononanoic acid |
|
|
|
|
|
99.9% |
| Perfluoroenanthic acid |
|
|
|
|
|
98.0% |
| Perfluoroenanthic acid-13C4 |
|
|
|
|
|
|
| Perfluoropentanoic acid |
|
|
|
|
|
98.0% |
| Hexadecanamide |
|
|
|
|
|
99.64% |
| Carbacyclin |
|
|
|
|
|
98.01% |
| Magnolol |
|
|
|
|
|
99.84% |
| Gemfibrozil |
|
|
|
|
|
99.89% |
| Gemfibrozil-d6 |
|
|
|
|
|
|
| Gemfibrozil (Standard) |
|
|
|
|
|
99.82% |
| Gemfibrozil 1-O-β-glucuronide |
|
|
|
|
|
99.76% |
| Pioglitazone-d4 |
|
|
|
|
|
99.34% |
| Pioglitazone-d4 (alkyl) |
|
|
|
|
|
98.55% |
| Pioglitazone |
|
|
|
|
|
99.70% |
| Pioglitazone potassium |
|
|
|
|
|
|
| Caudatin |
|
|
|
|
|
99.95% |
| Candesartan |
|
|
|
|
|
98.10% |
| Peliglitazar racemate |
|
|
|
|
|
|
| Karacoline |
|
|
|
|
|
99.58% |
| Soyasaponin Aa |
|
|
|
|
|
99.88% |
| Soyasaponin Ab |
|
|
|
|
|
98.23% |
| Daidzein-d4 |
|
|
|
|
|
98.93% |
| Daidzein (Standard) |
|
|
|
|
|
98.65% |
| Daidzein-3',5',8-d3 |
|
|
|
|
|
|
| Daidzein-d6 |
|
|
|
|
|
|
| Daidzein |
|
|
|
|
|
99.81% |
| Cefminox sodium |
|
|
|
|
|
99.83% |
| Octocrylene |
|
|
|
|
|
98.68% |
| Alpinetin |
|
|
|
|
|
99.51% |
| Asperosaponin VI |
|
|
|
|
|
99.62% |
| Balaglitazone |
|
|
|
|
|
99.25% |
| Isosilybin A |
|
|
|
|
|
99.63% |
| Eupatilin |
|
|
|
|
|
99.23% |
| Eupatilin (Standard) |
|
|
|
|
|
|
| Angeloylgomisin H |
|
|
|
|
|
99.79% |
| Avicularin (Standard) |
|
|
|
|
|
|
| Avicularin |
|
|
|
|
|
99.80% |
| Neoandrographolide |
|
|
|
|
|
99.41% |
| Neomangiferin |
|
|
|
|
|
99.80% |
| Troglitazone-d4 |
|
|
|
|
|
98.19% |
| Troglitazone |
|
|
|
|
|
99.78% |
| Tibric acid |
|
|
|
|
|
|
| Naringenin |
|
|
|
|
|
99.28% |
| (+)-Medioresinol |
|
|
|
|
|
99.13% |
| Palmitelaidic acid |
|
|
|
|
|
99.4% |
| Palmitelaidic acid-d13 |
|
|
|
|
|
99.0% |
| Arecaidine |
|
|
|
|
|
99.63% |
| Oleuropein |
|
|
|
|
|
99.97% |
| Auraptene |
|
|
|
|
|
99.97% |
| Flurbiprofen axetil |
|
|
|
|
|
99.34% |
| Clofibrate-d4 |
|
|
|
|
|
|
| Clofibrate (Standard) |
|
|
|
|
|
98.46% |
| Clofibrate |
|
|
|
|
|
99.53% |
| Clofibric acid-d4 |
|
|
|
|
|
|
| Clofibric acid |
|
|
|
|
|
99.92% |
| Saroglitazar |
|
|
|
|
|
|
| Saroglitazar magnesium |
|
|
|
|
|
98.02% |
| Falcarindiol |
|
|
|
|
|
97.62% |
| Lobeglitazone |
|
|
|
|
|
96.18% |
| Icariin (Standard) |
|
|
|
|
|
97.21% |
| Icariin |
|
|
|
|
|
99.06% |
| Fisetin-d5 |
|
|
|
|
|
|
| Fisetin |
|
|
|
|
|
99.90% |
| Ciprofibrate-d6 |
|
|
|
|
|
|
| Ciprofibrate (Standard) |
|
|
|
|
|
99.82% |
| Ciprofibrate |
|
|
|
|
|
99.93% |
| Ciglitazone |
|
|
|
|
|
99.74% |
| Phellopterin |
|
|
|
|
|
99.94% |
| Glycyrin |
|
|
|
|
|
98.0% |
| Esculeogenin A |
|
|
|
|
|
|
| Bilobetin |
|
|
|
|
|
99.71% |
| Inolitazone dihydrochloride |
|
|
|
|
|
98.45% |
| Pioglitazone hydrochloride |
|
|
|
|
|
99.97% |
| Rosiglitazone hydrochloride |
|
|
|
|
|
99.81% |
| Dehydroepiandrosterone sulfate sodium |
|
|
|
|
|
99.96% |
| Dehydroepiandrosterone sulfate sodium (Standard) |
|
|
|
|
|
98% |
| 9-Octadecynoic acid |
|
|
|
|
|
99.90% |
| Clitorin |
|
|
|
|
|
99.45% |
| Triphenyl phosphate |
|
|
|
|
|
98.0% |
| Monascin |
|
|
|
|
|
99.72% |
| Ankaflavin |
|
|
|
|
|
98.22% |
| Gypenoside XLIX |
|
|
|
|
|
99.88% |
| Rohitukine |
|
|
|
|
|
|
| Rosiglitazone |
|
|
|
|
|
99.94% |
| Rosiglitazone-d3 |
|
|
|
|
|
|
| Rosiglitazone-d4 |
|
|
|
|
|
|
| Rosiglitazone-d4-1 |
|
|
|
|
|
|
| Rosiglitazone sodium |
|
|
|
|
|
|
| Rosiglitazone potassium |
|
|
|
|
|
99.13% |
| 5-Aminosalicylic Acid-d3 hydrochloride |
|
|
|
|
|
99.00% |
| 5-Aminosalicylic acid-d3 |
|
|
|
|
|
99.38% |
| 5-Aminosalicylic acid-13C6 |
|
|
|
|
|
|
| 5-Aminosalicylic acid-d7 |
|
|
|
|
|
|
| 5-Aminosalicylic Acid |
|
|
|
|
|
99.97% |
| Mesalamine impurity P |
|
|
|
|
|
|
| 5-Aminosalicylic acid-d3 disodium |
|
|
|
|
|
|
| Cinnamyl Alcohol |
|
|
|
|
|
98.58% |
| Cinnamyl Alcohol-d5 |
|
|
|
|
|
|
| Cinnamyl Alcohol-d9 |
|
|
|
|
|
|
| Sulindac sulfone |
|
|
|
|
|
98.10% |
| Norathyriol |
|
|
|
|
|
99.74% |
| Anandamide |
|
|
|
|
|
98.43% |
| Keracyanin chloride |
|
|
|
|
|
99.90% |
| Arhalofenate |
|
|
|
|
|
99.85% |
| Rubrofusarin gentiobioside |
|
|
|
|
|
99.07% |
| Bezafibrate |
|
|
|
|
|
99.83% |
| Bezafibrate-d6 |
|
|
|
|
|
98.0% |
| Bezafibrate-13C6 |
|
|
|
|
|
|
| Bezafibrate-d4 |
|
|
|
|
|
|
| Inclisiran |
|
|
|
|
|
98.96% |
| Inclisiran sodium |
|
|
|
|
|
99.08% |
| Zinc Gluconate |
|
|
|
|
|
98.0% |
| Astaxanthin |
|
|
|
|
|
98.0% |
| Bavachinin |
|
|
|
|
|
99.95% |
| Schizophyllan |
|
|
|
|
|
|
| Fucoxanthin |
|
|
|
|
|
99.54% |
| Cetaben |
|
|
|
|
|
99.41% |
| Raspberry ketone-d5 |
|
|
|
|
|
|
| Raspberry ketone |
|
|
|
|
|
99.95% |
| 11-cis-Retinoic Acid-d5 |
|
|
|
|
|
|
| Retinoic acid (Standard) |
|
|
|
|
|
99.73% |
| Retinoic acid-d5 |
|
|
|
|
|
99.1% |
| Retinoic acid-d6 |
|
|
|
|
|
98.9% |
| Retinoic acid |
|
|
|
|
|
99.81% |
| Ochratoxin A |
|
|
|
|
|
99.92% |
| Ochratoxin A-d5 |
|
|
|
|
|
|
| Darglitazone |
|
|
|
|
|
99.05% |
| Darglitazone Sodium |
|
|
|
|
|
|
| Naveglitazar racemate |
|
|
|
|
|
|
| Convallatoxin |
|
|
|
|
|
99.72% |
| Adelmidrol |
|
|
|
|
|
98.0% |
| Aleglitazar |
|
|
|
|
|
99.74% |
| Norbixin |
|
|
|
|
|
|
| Fenofibrate |
|
|
|
|
|
99.97% |
| Fenofibrate-d6 |
|
|
|
|
|
99.70% |
| Fenofibrate (Standard) |
|
|
|
|
|
99.92% |
| Fenofibrate-13C6 |
|
|
|
|
|
|
| Fenofibrate-d4 |
|
|
|
|
|
|
| Choline Fenofibrate |
|
|
|
|
|
99.54% |
| Fenofibric acid |
|
|
|
|
|
99.94% |
| Fenofibric acid-d6 |
|
|
|
|
|
99.58% |
| Fenofibric acid (Standard) |
|
|
|
|
|
99.57% |
| Fenofibric acid-13C8 |
|
|
|
|
|
|
| Rosiglitazone maleate |
|
|
|
|
|
99.73% |
| Ophiopogonin D |
|
|
|
|
|
99.80% |
| Maltitol |
|
|
|
|
|
98.0% |
| Sinigrin |
|
|
|
|
|
99.92% |
| Sinigrin hydrate |
|
|
|
|
|
99.92% |